Explore

Rapid ReadRapid Read
Binaytara Works to Bridge Global Cancer Care Disparities Through Infrastructure, Education, and Research

Binaytara Works to Bridge Global Cancer Care Disparities Through Infrastructure, Education, and Research

Binaytara, a U.S.-based nonprofit organization, is dedicated to minimizing cancer health disparities globally through patient care, education, advocacy, and implementation-science research. The organization's work includes expanding access to cancer care in underserved regions, such as Madhesh Province in Nepal, where it established a cancer-care facility in 2018 and plans to build a 250-bed hospital. Binaytara also focuses on cervical cancer screening camps, particularly for women in Nepal, and strengthens the healthcare workforce through continuing medical education and professional development for oncology and hematology professionals in Nepal and Nigeria. Its research arm, the Binaytara Cancer Research Institute (BCRI), focuses on implementation-ready solutions for equity gaps in global cancer care.
Rapid ReadRapid Read
South Shore Health Emphasizes Early Prostate Cancer Detection for Improved Outcomes

South Shore Health Emphasizes Early Prostate Cancer Detection for Improved Outcomes

South Shore Health is highlighting the critical importance of early prostate cancer detection, particularly during Men's Health Awareness Month in November 2026. Prostate cancer is the second most common cancer among American men and the second leading cause of cancer death for men. The American Cancer Society (ACS) projects approximately 333,830 new cases and 36,320 deaths from prostate cancer in 2026. While primarily affecting older men (6 in 10 cases diagnosed at 65 or older), incidence rates have risen by 3% annually over the last decade. Radiation oncologist Peter F. Orio, III, DO, and Chief of Urology Sergio D. Fefer, MD, stress that early-stage prostate cancer often presents without symptoms, making routine screening crucial for better treatment options and more favorable outcomes. Screening typically involves periodic PSA-based testing and physical exams, with discussions between patients and clinicians to weigh benefits and harms based on individual risk factors.
TrendlineTrendline
Flatiron Health Presents Research on Global Oncology Evidence for Health Technology Assessment at ISPOR Europe 2026

Flatiron Health Presents Research on Global Oncology Evidence for Health Technology Assessment at ISPOR Europe 2026

Flatiron Health Presents Research on Global Oncology Evidence for Health Technology Assessment at ISPOR Europe 2026
Rapid ReadRapid Read
Precision Oncology Aims to Optimize Treatment Decisions by Characterizing Tumor Biology Earlier

Precision Oncology Aims to Optimize Treatment Decisions by Characterizing Tumor Biology Earlier

Precision oncology is striving to enhance treatment decisions by more deeply characterizing the biology of individual tumors at an earlier stage. This approach seeks to narrow therapeutic choices and reduce the time spent on ineffective treatments, ultimately making the initial treatment more likely to be successful. A recent JAMA Surgery analysis highlighted an increase in the time from diagnosis to first-course treatment across six major cancers between 2012 and 2023, emphasizing the urgency of this goal. The objective is not merely to expedite treatment but to accelerate access to the most effective treatment. By moving beyond simply cataloging mutations or identifying targets, precision oncology aims to understand the functional drivers of a tumor through methods like proteomics and phosphoproteomics, which examine proteins and their activation states. This allows clinicians to ask what is functionally driving the tumor and at what level, rather than just whether a potential target is present.
Rapid ReadRapid Read
Experts at COGC 2026 Emphasize Systemic Investments for Sustainable Precision Oncology

Experts at COGC 2026 Emphasize Systemic Investments for Sustainable Precision Oncology

At the Community Oncology Global Congress (COGC 2026), experts discussed the critical elements for making precision oncology sustainable, particularly outside major academic centers. The panel, moderated by Suman S. Karanth, Additional Director of Medical Oncology at Fortis Memorial Research Institute, included Soham Banerjee, Senior Consultant Genetic Counselor, and Atlal Abusanad, Professor of Medicine and Medical Oncology. The discussion moved beyond the availability of genomic testing to address practical challenges such as drug access when targets are identified, patient understanding of complex results, the utility of molecular tumor boards in smaller settings, and the reliance on Western genomic data. A key consensus was that the sustainability of precision oncology depends not just on the existence of tests but on the robust system built around them. This includes early genetic counseling, local genomic datasets, virtual molecular tumor boards, and better integration of genomic information into ele...
Rapid ReadRapid Read
University of Maryland, Baltimore Announces Call for Abstracts for 2027 Nursing Education Conference

University of Maryland, Baltimore Announces Call for Abstracts for 2027 Nursing Education Conference

The University of Maryland, Baltimore (UMB) has issued a call for abstracts for its Institute for Educators 2027 Annual Nursing Education Conference, scheduled for April 23, 2027. The planning committee is seeking submissions for 'Nursing Education (NED) Talks' and poster presentations. NED Talks are designed as 10-minute on-stage presentations where nurse educators can share innovative teaching strategies or technologies, followed by a 5-minute Q&A session. Poster presentations will highlight innovative teaching strategies, technologies, or evidence-based practices in nursing education through scholarly posters, offering interactive sessions for attendees and networking opportunities. Abstracts are due by Friday, December 18, 2026, at 11:59 p.m. Submissions must be made through an online process, and applicants are advised to review submission and abstract guidelines beforehand. The conference aims to provide a platform for nurse educators to share and advance nursing education.
Rapid ReadRapid Read
Study Reveals Alarming Rise in Vitamin K Deficiency in Newborns as Parental Refusals Increase

Study Reveals Alarming Rise in Vitamin K Deficiency in Newborns as Parental Refusals Increase

A nationwide study led by Elizabeth Wolf, M.D., MPH, a pediatrician at Children’s Hospital of Richmond at VCU, has found a significant increase in vitamin K deficiency (VKD) and vitamin-K-deficient bleeding (VKDB) in newborns across the U.S. The study, published in JAMA Pediatrics, analyzed over 11 million infant records from 2017 to 2025. It revealed that the percentage of newborns receiving injectable vitamin K decreased from 97.7% to 95.0% during this period. Concurrently, the rate of VKD increased by 216%, and VKDB increased by 347%. Researchers noted that only 40% of infants diagnosed with VKD and 19% of those with VKDB had received vitamin K shots. Approximately 7% of VKD cases and 2% of VKDB cases were associated with intracranial or intracerebral hemorrhage.
Rapid ReadRapid Read
Sutter Health Details 2026 Integrated Care Model and Patient Navigation Guidelines

Sutter Health Details 2026 Integrated Care Model and Patient Navigation Guidelines

Sutter Health, a prominent not-for-profit health system in Northern California, has outlined its operational framework and patient navigation guidelines for the 2026 plan year. The system emphasizes an 'integrated delivery network' model, where physicians are part of a coordinated care structure encompassing medical foundations, hospitals, and outpatient surgery centers. A key feature for 2026 is 'connected care,' ensuring primary care physicians (PCPs), specialists, and laboratory services share a centralized Electronic Health Record (EHR). Patients are advised to distinguish between directly employed Sutter Medical Foundation physicians and 'Sutter-affiliated' doctors who admit to Sutter hospitals but maintain independent practices. The guidelines also stress the importance of verifying insurance compatibility for 2026, recommending patients use their health plan's provider search portal for the most up-to-date network information. For HMO plans, PCPs must be designated in the health plan's database for ...
Rapid ReadRapid Read
Study Reveals Stemness-Associated Transcriptional Profiles in Osteosarcoma, Offering New Prognostic Insights

Study Reveals Stemness-Associated Transcriptional Profiles in Osteosarcoma, Offering New Prognostic Insights

A new research article published in Frontiers in Genetics, specifically in the section on Cancer Genetics and Oncogenomics, details a study on stemness-associated transcriptional profiles in osteosarcoma (OS). The study, titled 'Stemness-associated transcriptional profiles reveal prognostic and microenvironmental heterogeneity in osteosarcoma,' was published on November 6, 2026. Researchers investigated the relationships between stemness-associated gene expression, patient prognosis, and the tumor immune microenvironment in osteosarcoma, an aggressive primary bone malignancy. Using non-negative matrix factorization of stemness-associated gene expression, the study identified two exploratory OS subtypes with distinct prognoses in the TARGET-OS cohort. One subtype (C1) showed poorer survival and enrichment of metabolic and DNA repair programs, while the other (C2) was enriched for extracellular matrix and immune-related processes. The study also developed a nine-gene signature that stratified overall surviva...
TrendlineTrendline
Pittsburgh Emerges as Hub for Private Equity and Venture Capital, Driven by University Research

Pittsburgh Emerges as Hub for Private Equity and Venture Capital, Driven by University Research

Pittsburgh Emerges as Hub for Private Equity and Venture Capital, Driven by University Research
Rapid ReadRapid Read
GLP-1 Medications Influence U.S. Home Design and Waste Management Practices

GLP-1 Medications Influence U.S. Home Design and Waste Management Practices

The increasing use of GLP-1 medications in the U.S. is beginning to influence home design, particularly in kitchens and bathrooms, and is raising concerns about household waste management. According to an analysis by PwC, 21% of U.S. households currently include a GLP-1 user, up from 9% in January 2025. This shift is leading to trends like 'hidden kitchens' and more compact, efficient layouts, as users report reduced 'food noise' and a decreased need for large food storage and preparation areas. Concurrently, New York City has seen a significant increase in needlestick injuries among sanitation workers, tripling since 2023, with the Department of Sanitation identifying injectable medications, including GLP-1s, as a possible contributing factor. The city plans to more than double fines for improperly discarded household medical waste.
Rapid ReadRapid Read
AI-Based Decision Support System Shows Potential to Improve Multiple Myeloma Treatment Consistency

AI-Based Decision Support System Shows Potential to Improve Multiple Myeloma Treatment Consistency

A study published in Frontiers in Medicine investigated the potential of a probabilistic AI-based clinical decision support system, M-BOT, to improve treatment selection in multiple myeloma (MM). The research highlighted significant variability in treatment decisions among hematologists, with inter-expert agreement being extremely low. M-BOT, which integrates probabilistic modeling from clinical trial and real-world data, generated recommendations that were consistently associated with higher predicted response rates compared to physician-selected regimens. While concordance between experts and M-BOT was limited, regimens jointly selected by both demonstrated higher predicted response probabilities. The study suggests M-BOT could enhance consistency and identify more effective treatment options, though further validation in larger, multi-center studies is needed.